HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benchun Miao Selected Research

Alzheimer Disease (Alzheimer's Disease)

3/2012Identification of small molecule inhibitors of neurite loss induced by Aβ peptide using high content screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benchun Miao Research Topics

Disease

16Neoplasms (Cancer)
10/2021 - 01/2009
15Melanoma (Melanoma, Malignant)
10/2021 - 03/2015
2Disease Progression
01/2021 - 11/2020
2Bone Resorption
04/2018 - 12/2017
2Lung Neoplasms (Lung Cancer)
01/2018 - 11/2016
2Acquired Immunodeficiency Syndrome (AIDS)
07/2005 - 08/2004
1Residual Neoplasm
10/2021
1Colorectal Neoplasms (Colorectal Cancer)
10/2021
1Neural crest tumor
01/2021
1Sarcoma (Soft Tissue Sarcoma)
11/2020
1Basal Cell Carcinoma (Rodent Ulcer)
01/2020
1Spontaneous Remission
10/2018
1Neuroblastoma
10/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Carcinogenesis
11/2016
1Colonic Neoplasms (Colon Cancer)
07/2015
1Alzheimer Disease (Alzheimer's Disease)
03/2012
1Breast Neoplasms (Breast Cancer)
06/2011
1type 2C Congenital disorder of glycosylation
06/2011
1Amyloid Plaque
04/2009

Drug/Important Bio-Agent (IBA)

5Immune Checkpoint InhibitorsIBA
10/2021 - 10/2018
5Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2011
2RNA (Ribonucleic Acid)IBA
11/2020 - 11/2018
2Small Interfering RNA (siRNA)IBA
11/2020 - 06/2011
2Pharmaceutical PreparationsIBA
11/2019 - 07/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2017 - 07/2015
2VemurafenibIBA
07/2015 - 03/2015
2N- (((2- hydroxy- 5- nitrophenyl)amino)carbonothioyl)- 3,5- dimethylbenzamideIBA
06/2011 - 01/2009
2sulfated polymannuroguluronateIBA
07/2005 - 08/2004
2Anti-HIV Agents (AIDS Drugs)IBA
07/2005 - 08/2004
1Circulating Tumor DNAIBA
10/2021
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2020
1Collagenases (Collagenase)FDA Link
11/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
11/2019
1Fatty Acids (Saturated Fatty Acids)IBA
11/2019
1Small Cytoplasmic RNAIBA
11/2018
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2018
1alpha-2'-deoxythioguanosineIBA
10/2018
1NucleosidesIBA
10/2018
1invariant chain (Ii-Key)IBA
10/2018
1CalciumIBA
04/2018
1apo-10'-lycopenoic acidIBA
01/2018
1CytokinesIBA
01/2018
1LycopeneIBA
01/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
12/2017
1CryptoxanthinsIBA
11/2016
1ProvitaminsIBA
11/2016
1Carotenoids (Carotene)IBA
11/2016
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2016
1Messenger RNA (mRNA)IBA
11/2016
1Cyclin-Dependent Kinase Inhibitor p16IBA
01/2016
1Cyclin DIBA
01/2016
1Apoptosis Regulatory ProteinsIBA
04/2015
1SurvivinIBA
04/2015
1Peptides (Polypeptides)IBA
03/2012
1CalcineurinIBA
06/2011
1Substance PIBA
06/2011
1Immunoglobulin E (IgE)IBA
06/2011
1AntigensIBA
06/2011
1Dynamins (Dynamin)IBA
06/2011
1OligosaccharidesIBA
07/2010
1oligomannurarate sulfateIBA
07/2010
1Indicators and Reagents (Reagents)IBA
07/2010
1TubulinIBA
07/2010
1Antimitotic AgentsIBA
07/2010
1Biological ProductsIBA
04/2009
1LigandsIBA
01/2009
1AntibodiesIBA
01/2009
1MicellesIBA
01/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009
1Polysaccharides (Glycans)IBA
08/2004
1Fluorescein-5-isothiocyanate (FITC)IBA
08/2004

Therapy/Procedure

12Therapeutics
10/2021 - 01/2009
3Immunotherapy
01/2021 - 11/2018
1Aftercare (After-Treatment)
01/2020